Evidence map›Paper›PMID 33924205›Full record

ArticleInternational journal of molecular sciences2021

Repeated Irradiation with γ-Ray Induces Cancer Stemness through TGF-β-DLX2 Signaling in the A549 Human Lung Cancer Cell Line.

Hae-Ran Park, Yeo-Jin Choi, Jee-Young Kim, In-Gyu Kim, Uhee Jung

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hae-Ran ParkBiotechnology Research Division, Korea Atomic Energy Research Institute, Jeonbuk 56212, Korea.ORCID 0000-0002-0589-1039
Yeo-Jin ChoiBiotechnology Research Division, Korea Atomic Energy Research Institute, Jeonbuk 56212, Korea.
Jee-Young KimBiotechnology Research Division, Korea Atomic Energy Research Institute, Jeonbuk 56212, Korea.
In-Gyu KimEnvironmental Safety Evaluation Research Division, Korea Atomic Energy Research Institute, Daejeon 34057, Korea.
Uhee JungEnvironmental Safety Evaluation Research Division, Korea Atomic Energy Research Institute, Daejeon 34057, Korea.
Korea Atomic Energy Research Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) play an important role in cancer recurrence and metastasis. It is suggested that the CSC properties in heterogeneous cancer cells can be induced by ionizing radiation (IR). This study investigated the role of DLX2 in the radioresistance and CSC properties induced by IR in NSCLC cancer cells. Here, A549 cells were exposed to fractionated irradiation at a cumulative dose of 52 Gy (4 Gy × 13 times) for a generation of radioresistant cells. After fractionated irradiation, surviving A549 cells exhibited resistance to IR and enhanced expression of various cancer stem cell markers. They also showed upregulation of mesenchymal molecular markers and downregulation of epithelial molecular markers, correlating with an increase in the migration and invasion. Fractionated irradiation triggered the secretion of TGF-β1 and DLX2 expression. Interestingly, the increased DLX2 following fractionated irradiation seemed to induce the expression of the gene for the EGFR-ligand betacellulin via Smad2/3 signaling. To contrast, DLX2 knockdown dramatically decreased the expression of CSC markers, migration, and proliferation. Moreover, A549 cells expressing DLX2 shRNA formed tumors with a significantly smaller volume compared to those expressing control shDNA in a mouse xenograft assay. These results suggest that DLX2 overexpression in surviving NSCLC cancer cells after fractionated IR exposure is involved in the cancer stemness, radioresistance, EMT, tumor survival, and tumorigenic capability.

Indexed as

Gamma RaysA549 CellsAnimalsCell Line, TumorCell MovementCell Self RenewalDisease Models, AnimalDose-Response Relationship, RadiationGene Knockout TechniquesHomeodomain ProteinsHumansMiceNeoplastic Stem CellsRadiation ToleranceRNA InterferenceRNA, Small InterferingDLX2 protein, humanHomeodomain ProteinsRNA, Small InterferingTranscription FactorsTransforming Growth Factor betacancer stem cellDLX2epithelial to mesenchymal transition (EMT)ionizing radiationnon-small cell lung cancerradioresistance

Identifiers

PMID33924205
PMCPMC8074596
OpenAlexW3155366489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.